Daniel brings significant life sciences strategy experience to Locust Walk. Prior to joining the team, he was a Consultant at Health Advances, a global healthcare management and strategy consulting firm, where he led projects with biopharmaceutical, medical technology, and private equity clients. He has substantial functional experience in portfolio management, asset forecasting and valuation, new opportunity prioritization, and business development and transaction support. He also carries extensive domain expertise in oncology, immunology, orphan disease, neurology, respiratory, and metabolic diseases, as well as domestic and international drug pricing and reimbursement.
Prior to joining Health Advances, Daniel completed a MS in Biotechnology at Brandeis University. While he was a student, he held various business strategy and portfolio management internships and was a researcher in a cryo-electron microscopy lab.
Daniel holds an MS in Biotechnology and a BS in Biology and Business from Brandeis University. He enjoys skiing, hiking, cooking, and weightlifting in his free time and co-organizes an LGBTQ beer club in Boston.
He is a FINRA registered representative and holds his Series 79 and 63 licenses.